Ji Yuanyuan, Wang Yuekun, Zhang Ning, Yang Junhong, Li Jing, Zheng Hui, Wang Lihua, Wang Weijie, Li Junkuo
Department of Oncology, Anyang Tumor Hospital, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang 455000, China.
Department of Surgical Oncology, Anyang Tumor Hospital, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang 455000, China.
Hum Immunol. 2024 Nov;85(6):111150. doi: 10.1016/j.humimm.2024.111150. Epub 2024 Oct 2.
It is reported that G protein-coupled receptor 84 (GPR84) can participate in inflammation and immune regulation to repress anti-tumor responses. However, the function of GPR84 in lung cancer (LC) and its potential molecular mechanisms are still largely unknown.
Bioinformatics and molecular experiments were employed to assess the expression of GPR84 in LC. The pathways enriched by GPR84 were analyzed by the Kyoto Encyclopedia of Genes and Genomes. Bioinformatics prediction identified the potential upstream regulatory factors of GPR84, which were verified through dual luciferase and chromatin immunoprecipitation experiments. Cell viability was measured by methyl thiazolyl tetrazolium assay. The expression levels of key proteins related to the janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway such as JAK2, p-JAK2, p-STAT3, and STAT3 were detected by western blot. Macrophages were co-cultured with LC cells. Flow cytometry was employed to examine the proportion of mannose receptor-positive cells. The expression levels of M2 polarization marker genes chitinase-like protein 3, arginase-1, and found in inflammatory zone 1 were measured by quantitative reverse transcription polymerase chain reaction. We applied an enzyme-linked immunosorbent assay to determine levels of cytokines (interleukin-10 and transforming growth factor beta) to evaluate the M2 macrophage polarization.
GPR84 was highly expressed in LC and substantially enriched in the JAK-STAT pathway. GPR84 facilitated the M2 polarization of macrophages in LC. Adding the JAK-STAT pathway inhibitor weakened the promoting effect of GPR84 overexpression on M2 macrophage polarization. Furthermore, GPR84 also had an upstream regulatory factor lamin B1 (LMNB1). Knocking down LMNB1 blocked the JAK-STAT signaling pathway to repress M2 macrophage polarization in LC, while overexpression of GPR84 reversed the impact of LMNB1 knockdown on macrophage polarization.
The project suggested that the LMNB1/GPR84 axis can facilitate M2 polarization of macrophages in LC by triggering the JAK-STAT pathway. Targeting LMNB1/GPR84 or blocking the JAK-STAT pathway may be a novel approach for LC diagnosis and treatment.
据报道,G蛋白偶联受体84(GPR84)可参与炎症和免疫调节,从而抑制抗肿瘤反应。然而,GPR84在肺癌(LC)中的功能及其潜在分子机制仍不清楚。
采用生物信息学和分子实验评估GPR84在肺癌中的表达。通过京都基因与基因组百科全书分析GPR84富集的通路。通过生物信息学预测确定GPR84的潜在上游调节因子,并通过双荧光素酶和染色质免疫沉淀实验进行验证。采用甲基噻唑基四氮唑法检测细胞活力。通过蛋白质免疫印迹法检测与Janus激酶(JAK)-信号转导和转录激活因子(STAT)通路相关的关键蛋白JAK2、p-JAK2、p-STAT3和STAT3的表达水平。将巨噬细胞与肺癌细胞共培养。采用流式细胞术检测甘露糖受体阳性细胞的比例。通过定量逆转录聚合酶链反应检测M2极化标志物基因几丁质酶样蛋白3、精氨酸酶-1和炎症区域1中发现的蛋白的表达水平。我们采用酶联免疫吸附测定法测定细胞因子(白细胞介素-10和转化生长因子β)水平,以评估M2巨噬细胞极化。
GPR84在肺癌中高表达,且在JAK-STAT通路中显著富集。GPR84促进肺癌中巨噬细胞的M2极化。添加JAK-STAT通路抑制剂可减弱GPR84过表达对M2巨噬细胞极化的促进作用。此外,GPR84还有一个上游调节因子核纤层蛋白B1(LMNB1)。敲低LMNB1可阻断JAK-STAT信号通路,从而抑制肺癌中M2巨噬细胞极化,而GPR84过表达可逆转LMNB1敲低对巨噬细胞极化的影响。
该研究表明,LMNB1/GPR84轴可通过激活JAK-STAT通路促进肺癌中巨噬细胞的M2极化。靶向LMNB1/GPR84或阻断JAK-STAT通路可能是肺癌诊断和治疗的新方法。